Diabetes

Semaglutide Approved for Adults With Type 2 Diabetes

Semaglutide Approved for Adults With Type 2 Diabetes

By

The FDA has approved semaglutide injection for the treatment of type 2 diabetes in adults.

Severe Hypoglycemia May Serve as CV Risk Marker in Diabetes

Severe Hypoglycemia May Serve as CV Risk Marker in Diabetes

Severe hypoglycemia is associated with high absolute risk of cardiovascular events and mortality in patients with diabetes.

Cardiovascular Outcomes With Insulin-Induced Weight Gain in T2D

Cardiovascular Outcomes With Insulin-Induced Weight Gain in T2D

By

Weight gain associated with insulin therapy is not associated with adverse cardiovascular outcomes in people with type 2 diabetes.

Incident Diabetes May Account for Link Between Sleep Duration and CHD

Incident Diabetes May Account for Link Between Sleep Duration and CHD

By

The association between sleep duration and incident diabetes may be similar to the association between sleep duration and incident coronary heart disease.

Hospitalization Rates for CVD With, Without Diabetes Decline

Hospitalization Rates for CVD With, Without Diabetes Decline

CVD hospitalization rates have declined in recent years among individuals with and those without diabetes.

High BMI, Diabetes Contribute to Incident Cancers Worldwide

High BMI, Diabetes Contribute to Incident Cancers Worldwide

More than 5% of all incident cancers in 2012 were attributable to diabetes and high body mass index.

Obesity and T2DM Diminish Brain's Response to Hyperglycemia

Obesity and T2DM Diminish Brain's Response to Hyperglycemia

The rise of brain glucose levels is blunted during hyperglycemia in adults with obesity and type 2 diabetes mellitus.

Sudden Cardiac Death Risk Increased in Young Patients With Diabetes

Sudden Cardiac Death Risk Increased in Young Patients With Diabetes

Children and young adults with diabetes mellitus have a fivefold increased risk of all-cause mortality and a sevenfold increased risk of sudden cardiac death compared with age-matched individuals without diabetes mellitus.

Cardiovascular Risks With Severe Hypoglycemia in Type 2 Diabetes

Cardiovascular Risks With Severe Hypoglycemia in Type 2 Diabetes

By

The study investigates the correlation between hypoglycemia and the risk for all-cause mortality in patients with type 2 diabetes.

Diabetes Risk in Coronary Heart Disease Reduced With Acarbose

Diabetes Risk in Coronary Heart Disease Reduced With Acarbose

By

Acarbose, an α-glucosidase inhibitor, decreased the incidence of diabetes in a population with impaired glucose tolerance at low risk of cardiovascular events.

High-Dose Beta-Blockers Associated With Lower Mortality in HF, Diabetes

High-Dose Beta-Blockers Associated With Lower Mortality in HF, Diabetes

By

Patients with chronic heart failure and diabetes may have a greater reduction in mortality with higher beta-blocker doses.

ACE Inhibitors, Statins Do Not Alter Albumin-to-Creatinine Ratio in Adolescents With T1D

ACE Inhibitors, Statins Do Not Alter Albumin-to-Creatinine Ratio in Adolescents With T1D

Neither ACE inhibitors nor statins change the albumin-to-creatinine ratio in adolescents with T1D.

Long-Term Prognosis in Heart Failure Worse With Diabetes

Long-Term Prognosis in Heart Failure Worse With Diabetes

Long-term prognosis among patients with acute heart failure is worse in those who have diabetes than in those who do not.

Arterial Stiffness May Be Early Marker for Diabetes

Arterial Stiffness May Be Early Marker for Diabetes

Increased arterial stiffness is associated with increased incidence of diabetes.

Sudden Death Most Common Cause of CV Death in Diabetes and Atherosclerotic CVD

Sudden Death Most Common Cause of CV Death in Diabetes and Atherosclerotic CVD

Sudden death is the most common category of cardiovascular mortality among patients with type 2 diabetes and atherosclerotic CVD.

Yoga Plus Aerobics Beneficial in Coronary Heart Disease

Yoga Plus Aerobics Beneficial in Coronary Heart Disease

For coronary heart disease patients with type 2 diabetes, combined Indian yoga and aerobic exercise is associated with greater improvement in heart disease risk factors.

Cardiovascular Event Risk Not Increased With Liraglutide

Cardiovascular Event Risk Not Increased With Liraglutide

Liraglutide treatment for weight management is not associated with increased risk of cardiovascular event.

Type 2 Diabetes Risks in Heart Failure Can Be Stratified by Glycemic Control

Type 2 Diabetes Risks in Heart Failure Can Be Stratified by Glycemic Control

For patients with heart failure, the risks conferred by type 2 diabetes can be stratified by glycemic control and drug treatments

LV Diastolic Function Improved in Diabetes With Pioglitazone

LV Diastolic Function Improved in Diabetes With Pioglitazone

Pioglitazone improves whole-body and myocardial insulin sensitivity, left ventricular diastolic function, and systolic function in patients with type 2 diabetes.

Insulin Resistance, Cardiometabolic Risk Increased in Obese Children

Insulin Resistance, Cardiometabolic Risk Increased in Obese Children

Cardiometabolic risk and homeostatic model assessment of insulin resistance increase with increased body mass index.

Insulin Dose Not Tied to Cardiovascular Outcomes

Insulin Dose Not Tied to Cardiovascular Outcomes

Cardiovascular outcomes in patients with diabetes are not explained by insulin resistance.

Prognostic Significance of Gender in Atrial Fibrillation and Diabetes

Prognostic Significance of Gender in Atrial Fibrillation and Diabetes

By

Women with atrial fibrillation and diabetes have higher rates for mortality and cardiovascular disease compared to men.

Cardiovascular Risk in Type 2 Diabetes Not Increased With Exenatide

Cardiovascular Risk in Type 2 Diabetes Not Increased With Exenatide

The risk of major cardiovascular events is similar for those receiving exenatide or placebo for patients with type 2 diabetes.

ADA Issues Position Statement on Hypertension Management in Diabetes

ADA Issues Position Statement on Hypertension Management in Diabetes

By

The American Diabetes Association has updated its recommendations on the assessment and treatment of hypertension in individuals with diabetes.

SGLT2 vs DPP4 Medications Associated with Lower Heart Failure Hospitalizations in Type 2 Diabetes

SGLT2 vs DPP4 Medications Associated with Lower Heart Failure Hospitalizations in Type 2 Diabetes

By

Patients with type 2 diabetes who received sodium-glucose co-transporter 2 inhibitors vs dipeptidyl peptidase-4 inhibitors had a lower risk for heart failure hospitalizations.

Atrial Fibrillation Risk Increased With Type 1 Diabetes, Poor Renal Function

Atrial Fibrillation Risk Increased With Type 1 Diabetes, Poor Renal Function

By

Patients with type 1 diabetes have an increased risk for atrial fibrillation.

Liraglutide Receives FDA Approval For MACE Reduction in Type 2 Diabetes

Liraglutide Receives FDA Approval For MACE Reduction in Type 2 Diabetes

By

Liraglutide has received approval by the US Food and Drug Administration for a new indication to reduce the risk of MACE in type 2 diabetes patients.

Type 2 Diabetes Medication Adherence Not Reported in Studies

Type 2 Diabetes Medication Adherence Not Reported in Studies

Studies often fail to include information on outcomes by medication adherence in type 2 diabetes.

Independent Predictors of Silent Coronary Artery Disease in Asymptomatic Diabetes

Independent Predictors of Silent Coronary Artery Disease in Asymptomatic Diabetes

By

Smoking, duration of diabetes, and male sex were among several independent predictors of silent coronary artery disease in patients with asymptomatic diabetes.

Benefits of Intensive SBP Treatment Extend to Patients WIth Prediabetes

Benefits of Intensive SBP Treatment Extend to Patients WIth Prediabetes

The beneficial effects of intensive systolic blood pressure treatment are similar among those with prediabetes and fasting normoglycemia.

Sign Up for Free e-Newsletters